Recent Advances in the Management of Non-Melanoma Skin Cancers

Dr Nikhil Khushalani reviews recent data updates for the treatment of non-melanoma skin cancers focusing on cutaneous squamous cell carcinoma and basal cell carcinoma.

EP. 1: Overview of Cutaneous Squamous Cell Carcinoma (cSCC)

October 19th 2022

Dr Khushalani defines cutaneous squamous cell carcinoma (cSCC), reviews the risk factors associated, and explains the staging system for patients diagnosed with cSCC.

EP. 2: Treatment Options for Patients with cSCC in the Neoadjuvant Setting

October 19th 2022

An overview of treatment options for patients for with cSCC, focusing on the neoadjuvant setting.

EP. 3: Current Treatment Options for Patients with Advanced Cutaneous Squamous Cell Carcinoma (cSCC)

October 21st 2022

Glenn J Hanna, MD, provides a brief overview of cutaneous squamous cell carcinoma (cSCC), and discusses the currently available treatment options for patients with advanced cSCC.

EP. 4: Review of Updated Efficacy and Safety Data from the EMPOWER-CSCC-1 Trial

October 21st 2022

Dr Hanna comments on updated efficacy and safety data of the EMPOWER-CSCC-1 trial that was recently discussed at the annual ESMO and ASCO 2022 meetings.

EP. 5: Role of Cemiplimab in the Neoadjuvant Setting for Patients with cSCC

October 26th 2022

Nikhil Khushalani, MD, comments on updated data evaluating the use of cemiplimab in the neoadjuvant setting for patients with cSCC.

EP. 6: Real-World Data of Cemiplimab in Patients with Advanced cSCC

October 26th 2022

Dr Khushalani provides insights into real-world data that was recently discussed at ESMO 2022 assessing the use of cemiplimab in patients with advanced cSCC.

EP. 7: Investigational Agents for the Treatment of Advanced cSCC

October 28th 2022

Dr Hanna highlights investigational agents that are being studied for the treatment of advanced cSCC and discuss some unmet needs for cSCC.

EP. 8: An Overview of Advanced Basal Cell Carcinoma (BCC) and Currently Available Treatment Options

October 28th 2022

Dr Hanna defines basal cell carcinoma (BCC), reviews current treatment options and explains the role of cemiplimab for the treatment of advanced BCC.

EP. 9: Future Perspectives in cSCC

November 2nd 2022

Dr Khushalani discusses challenges faced when treating patients with cSCC and shares advice for fellow colleagues who treat patients with cSCC.

EP. 10: Treatment Options for Patients with Advanced Basal Cell Carcinoma (BCC)

November 2nd 2022

An expert provides a brief overview of basal cell carcinoma (BCC) and reviews currently available treatment options for patients with BCC.

EP. 11: Looking Ahead: Unmet Needs for the Treatment of BCC

November 9th 2022

Nikhil Khushalani, MD, comments on upcoming treatment advances he looks forward to for patients with BCC.